Novo Nordisk wins Dutch injunction in semaglutide patent case
The court ruling adds to Novo's expanding litigation campaign against semaglutide copies in European markets.
DO
By Daniel Okafor · Regulatory Correspondent
Aug 5 03:00 ETSource: Reuters
The wire
- 01A Dutch court granted Novo Nordisk an injunction in a semaglutide patent infringement case, per Reuters.
- 02European supply channels and generic or compounded semaglutide routes narrow as Novo enforces patents jurisdiction by jurisdiction.
- 03Details of the defendant, scope of the injunction and any appeal are not given in the summary available.
From the source
Read at reuters.comNovo Nordisk wins Dutch court injunction in semaglutide patent infringement case